Literature DB >> 10935508

Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

S Yi1, M S Tsao.   

Abstract

Hepatocyte growth factor (HGF) is a multifunctional cytokine with effects on the proliferation, motility, and differentiation of cells that express its receptor Met. The co-expression of HGF and Met is common among nonsmall-cell lung cancers, especially adenocarcinoma. However, the biologic consequences of this putative HGF-Met autocrine signaling remain speculative. We have used retroviral gene transduction technique to express high levels of HGF in the NCI-H358 lung adenocarcinoma cells that have functionally active cell surface Met receptor. The activation of autocrine HGF-Met signaling was confirmed by the induction of spontaneous cell scattering activity. Compared to the parent and control cells transduced with the retroviral vector alone, HGF overexpressing H358 cells show enhanced capacity to colonize soft agar medium and to form xenograft tumors when implanted in the subcutaneous tissue of immune-deficient mice. These effects were not accompanied by changes in their growth rate in monolayer culture condition, or in the expression of vascular endothelial growth factor. The tumors formed by HGF overexpressing cells also showed more prominent glandular cell arrangement and functional activity. This report provides the direct in vivo evidence that autocrine HGF-Met signaling plays significant roles in the growth and differentiation of human lung adenocarcinoma cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10935508      PMCID: PMC1507572          DOI: 10.1038/sj.neo.7900080

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  45 in total

1.  Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor.

Authors:  H Takayama; W J LaRochelle; R Sharp; T Otsuka; P Kriebel; M Anver; S A Aaronson; G Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.

Authors:  J M Siegfried; L A Weissfeld; P Singh-Kaw; R J Weyant; J R Testa; R J Landreneau
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

3.  Immunoreactivity for hepatocyte growth factor/scatter factor and its receptor, met, in human lung carcinomas and malignant mesotheliomas.

Authors:  P Harvey; A Warn; P Newman; L J Perry; R Y Ball; R M Warn
Journal:  J Pathol       Date:  1996-12       Impact factor: 7.996

Review 4.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

5.  Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells.

Authors:  E W Lam; R Zwacka; J F Engelhardt; B L Davidson; F E Domann; T Yan; L W Oberley
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

6.  Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.

Authors:  K Lamszus; L Jin; A Fuchs; E Shi; S Chowdhury; Y Yao; P J Polverini; J Laterra; I D Goldberg; E M Rosen
Journal:  Lab Invest       Date:  1997-03       Impact factor: 5.662

7.  NCI-Navy Medical Oncology Branch cell line data base.

Authors:  R M Phelps; B E Johnson; D C Ihde; A F Gazdar; D P Carbone; P R McClintock; R I Linnoila; M J Matthews; P A Bunn; D Carney; J D Minna; J L Mulshine
Journal:  J Cell Biochem Suppl       Date:  1996

8.  Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.

Authors:  J Laterra; M Nam; E Rosen; J S Rao; K Lamszus; I D Goldberg; P Johnston
Journal:  Lab Invest       Date:  1997-04       Impact factor: 5.662

Review 9.  The roles of hepatocyte growth factor/scatter factor and met receptor in human cancers (Review).

Authors:  C T To; M S Tsao
Journal:  Oncol Rep       Date:  1998 Sep-Oct       Impact factor: 3.906

10.  Paracrine effects of hepatocyte growth factor/scatter factor on non-small-cell lung carcinoma cell lines.

Authors:  S Yi; J R Chen; J Viallet; R H Schwall; T Nakamura; M S Tsao
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more
  19 in total

Review 1.  Prognostic value of c-Met in colorectal cancer: a meta-analysis.

Authors:  Yan Liu; Xiao-Feng Yu; Jian Zou; Zi-Hua Luo
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

2.  The MET axis as a therapeutic target.

Authors:  Martin Sattler; Ravi Salgia
Journal:  Update Cancer Ther       Date:  2009-04-01

3.  c-MET as a potential therapeutic target and biomarker in cancer.

Authors:  J Rafael Sierra; Ming-Sound Tsao
Journal:  Ther Adv Med Oncol       Date:  2011-11       Impact factor: 8.168

4.  Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.

Authors:  Roya Navab; Jiang Liu; Isolde Seiden-Long; Warren Shih; Ming Li; Bizhan Bandarchi; Yan Chen; Davina Lau; Yen-Fen Zu; Dave Cescon; Chang Qi Zhu; Shawna Organ; Emin Ibrahimov; Dina Ohanessian; Ming-Sound Tsao
Journal:  Neoplasia       Date:  2009-12       Impact factor: 5.715

Review 5.  Modulation of c-Met signaling and cellular sensitivity to radiation: potential implications for therapy.

Authors:  Vikas Bhardwaj; Tina Cascone; Maria Angelica Cortez; Arya Amini; Jaden Evans; Ritsuko U Komaki; John V Heymach; James W Welsh
Journal:  Cancer       Date:  2013-02-19       Impact factor: 6.860

6.  Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice.

Authors:  Xiao-Ping Chen; Xin-Ping Ren; Jian-Yun Lan; You-Guo Chen; Zong-Ji Shen
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

Review 7.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

Review 8.  c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.

Authors:  Martin Sattler; Ravi Salgia
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

Review 9.  MET as a possible target for non-small-cell lung cancer.

Authors:  Ahad A Sadiq; Ravi Salgia
Journal:  J Clin Oncol       Date:  2013-02-11       Impact factor: 44.544

Review 10.  The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis.

Authors:  Weon-Kyoo You; Donald M McDonald
Journal:  BMB Rep       Date:  2008-12-31       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.